Acebutolol
Alfuzosin may increase the hypotensive activities of Acebutolol.
Adrafinil
Alfuzosin may decrease the vasoconstricting activities of Adrafinil.
Albuterol
Alfuzosin may decrease the vasoconstricting activities of Salbutamol.
Advertisement
Aliskiren
Alfuzosin may increase the hypotensive activities of Aliskiren.
Alogliptin
The serum concentration of Alfuzosin can be increased when it is combined with Alogliptin.
alpha 1-Antitrypsin
The serum concentration of Alfuzosin can be increased when it is combined with Alpha-1-proteinase inhibitor.
Advertisement
Alpha 1-Proteinase Inhibitor, Human
The serum concentration of Alfuzosin can be increased when it is combined with Alpha-1-proteinase inhibitor.
Alprenolol
Alfuzosin may increase the hypotensive activities of Alprenolol.
Ambrisentan
Alfuzosin may increase the hypotensive activities of Ambrisentan.
Advertisement
Amiodarone
The serum concentration of Alfuzosin can be increased when it is combined with Amiodarone.
Amlodipine
Alfuzosin may increase the hypotensive activities of Amlodipine.
Amprenavir
The serum concentration of Alfuzosin can be increased when it is combined with Amprenavir.
Anagrelide
Alfuzosin may increase the QTc-prolonging activities of Anagrelide.
Antithrombin III
The serum concentration of Alfuzosin can be increased when it is combined with Antithrombin III human.
Antithrombin III, Human
The serum concentration of Alfuzosin can be increased when it is combined with Antithrombin III human.
Apalutamide
The serum concentration of Alfuzosin can be decreased when it is combined with Apalutamide.
Apixaban
The serum concentration of Alfuzosin can be increased when it is combined with Apixaban.
Apraclonidine
Alfuzosin may decrease the vasoconstricting activities of Apraclonidine.
Aprepitant
The serum concentration of Alfuzosin can be increased when it is combined with Aprepitant.
Aprotinin
The serum concentration of Alfuzosin can be increased when it is combined with Aprotinin.
Arbutamine
Alfuzosin may decrease the vasoconstricting activities of Arbutamine.
Arformoterol
Alfuzosin may decrease the vasoconstricting activities of Arformoterol.
Argatroban
The serum concentration of Alfuzosin can be increased when it is combined with Argatroban.
Argatroban Anhydrous
The serum concentration of Alfuzosin can be increased when it is combined with Argatroban.
Arsenic Trioxide
Alfuzosin may increase the QTc-prolonging activities of Arsenic trioxide.
Artemether
Alfuzosin may increase the QTc-prolonging activities of Artemether.
Asenapine
Alfuzosin may increase the QTc-prolonging activities of Asenapine.
Asunaprevir
The serum concentration of Alfuzosin can be increased when it is combined with Asunaprevir.
Atazanavir
The serum concentration of Alfuzosin can be increased when it is combined with Atazanavir.
Atenolol
Alfuzosin may increase the hypotensive activities of Atenolol.
Atomoxetine
The metabolism of Alfuzosin can be decreased when combined with Atomoxetine.
Avanafil
Avanafil may increase the hypotensive activities of Alfuzosin.
Azithromycin
Alfuzosin may increase the QTc-prolonging activities of Azithromycin.
Bedaquiline
Alfuzosin may increase the QTc-prolonging activities of Bedaquiline.
Benazepril
The serum concentration of Alfuzosin can be increased when it is combined with Benazepril.
Bencyclane
The risk or severity of hypotension can be increased when Alfuzosin is combined with Bencyclane.
Bendroflumethiazide
Alfuzosin may increase the hypotensive activities of Bendroflumethiazide.
Bepridil
Alfuzosin may increase the hypotensive activities of Bepridil.
Betaxolol
Alfuzosin may increase the hypotensive activities of Betaxolol.
Bethanidine
Alfuzosin may increase the hypotensive activities of Bethanidine.
Bimatoprost
Alfuzosin may increase the hypotensive activities of Bimatoprost.
Bisoprolol
Alfuzosin may increase the hypotensive activities of Bisoprolol.
Bitolterol
Alfuzosin may decrease the vasoconstricting activities of Bitolterol.
Bitolterol Mesylate
Alfuzosin may decrease the vasoconstricting activities of Bitolterol.
Bivalirudin
The serum concentration of Alfuzosin can be increased when it is combined with Bivalirudin.
Boceprevir
The serum concentration of Alfuzosin can be increased when it is combined with Boceprevir.
Bopindolol
Bopindolol may increase the orthostatic hypotensive activities of Alfuzosin.
Bortezomib
The metabolism of Alfuzosin can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Alfuzosin can be decreased when it is combined with Bosentan.
Bretylium
Alfuzosin may increase the hypotensive activities of Bretylium.
Brimonidine
Alfuzosin may increase the hypotensive activities of Brimonidine.
Bunazosin
Alfuzosin may increase the antihypertensive activities of Bunazosin.
Bupranolol
Alfuzosin may increase the hypotensive activities of Bupranolol.
Cafedrine
Alfuzosin may increase the hypotensive activities of Cafedrine.
Candesartan
Alfuzosin may increase the hypotensive activities of Candesartan.
Candesartan Cilexetil
Alfuzosin may increase the hypotensive activities of Candesartan cilexetil.
Captopril
The serum concentration of Alfuzosin can be increased when it is combined with Captopril.
Carbamazepine
The metabolism of Alfuzosin can be increased when combined with Carbamazepine.
Carteolol
Alfuzosin may increase the hypotensive activities of Carteolol.
Carvedilol
Alfuzosin may increase the hypotensive activities of Carvedilol.
Celiprolol
Alfuzosin may increase the hypotensive activities of Celiprolol.
Ceritinib
The serum concentration of Alfuzosin can be increased when it is combined with Ceritinib.
Chloroquine
Alfuzosin may increase the QTc-prolonging activities of Chloroquine.
Chlorothiazide
Alfuzosin may increase the hypotensive activities of Chlorothiazide.
Chlorpromazine
Alfuzosin may increase the QTc-prolonging activities of Chlorpromazine.
Chlorthalidone
Alfuzosin may increase the hypotensive activities of Chlorthalidone.
Cholesterol
The serum concentration of Alfuzosin can be increased when it is combined with Cholesterol.
Cicletanine
Alfuzosin may increase the hypotensive activities of Cicletanine.
Cilastatin
The serum concentration of Alfuzosin can be increased when it is combined with Cilastatin.
Cilazapril
The serum concentration of Alfuzosin can be increased when it is combined with Cilazapril.
Cinnarizine
The risk or severity of hypotension can be increased when Alfuzosin is combined with Cinnarizine.
Ciprofloxacin
Alfuzosin may increase the QTc-prolonging activities of Ciprofloxacin.
Cisapride
Alfuzosin may increase the QTc-prolonging activities of Cisapride.
Citalopram
Alfuzosin may increase the QTc-prolonging activities of Citalopram.
Clarithromycin
The serum concentration of Alfuzosin can be increased when it is combined with Clarithromycin.
Clemastine
The metabolism of Alfuzosin can be decreased when combined with Clemastine.
Clenbuterol
Alfuzosin may decrease the vasoconstricting activities of Clenbuterol.
Clevidipine
The risk or severity of hypotension can be increased when Alfuzosin is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of hypotension can be increased when Alfuzosin is combined with Clevidipine.
Clonidine
Alfuzosin may increase the hypotensive activities of Clonidine.
Clotrimazole
The metabolism of Alfuzosin can be decreased when combined with Clotrimazole.
Clozapine
Alfuzosin may increase the QTc-prolonging activities of Clozapine.
Cobicistat
The serum concentration of Alfuzosin can be increased when it is combined with Cobicistat.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Alfuzosin.
Crizotinib
The metabolism of Alfuzosin can be decreased when combined with Crizotinib.
Cryptenamine
Alfuzosin may increase the hypotensive activities of Cryptenamine.
Cyclandelate
The risk or severity of hypotension can be increased when Alfuzosin is combined with Cyclandelate.
Cyclopenthiazide
Alfuzosin may increase the hypotensive activities of Cyclopenthiazide.
Cyclosporine
The metabolism of Alfuzosin can be decreased when combined with Cyclosporine.
Cyclothiazide
Alfuzosin may increase the hypotensive activities of Cyclothiazide.
Dabigatran Etexilate
The serum concentration of Alfuzosin can be increased when it is combined with Dabigatran etexilate.
Dabrafenib
The serum concentration of Alfuzosin can be decreased when it is combined with Dabrafenib.
Darunavir
The serum concentration of Alfuzosin can be increased when it is combined with Darunavir.
Dasatinib
The serum concentration of Alfuzosin can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Alfuzosin can be increased when it is combined with Dasatinib.
Debrisoquin
Alfuzosin may increase the hypotensive activities of Debrisoquin.
Deferasirox
The serum concentration of Alfuzosin can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Alfuzosin can be decreased when combined with Delavirdine.
Deserpidine
Alfuzosin may increase the hypotensive activities of Deserpidine.
Dexmedetomidine
Alfuzosin may decrease the vasoconstricting activities of Dexmedetomidine.
Diazoxide
Alfuzosin may increase the hypotensive activities of Diazoxide.
Dihydralazine
Alfuzosin may increase the hypotensive activities of Dihydralazine.
Dihydroergotamine
The metabolism of Alfuzosin can be decreased when combined with Dihydroergotamine.
Diltiazem
Alfuzosin may increase the hypotensive activities of Diltiazem.
Dipivefrin
Alfuzosin may decrease the vasoconstricting activities of Dipivefrin.
Disopyramide
Alfuzosin may increase the QTc-prolonging activities of Disopyramide.
Dobutamine
Alfuzosin may decrease the vasoconstricting activities of Dobutamine.
Dofetilide
Alfuzosin may increase the QTc-prolonging activities of Dofetilide.
Dolasetron
Alfuzosin may increase the QTc-prolonging activities of Dolasetron.
Domperidone
Alfuzosin may increase the QTc-prolonging activities of Domperidone.
Dopexamine
Alfuzosin may decrease the vasoconstricting activities of Dopexamine.
Dorzolamide
Alfuzosin may increase the hypotensive activities of Dorzolamide.
Doxazosin
Alfuzosin may increase the hypotensive activities of Doxazosin.
Doxycycline
The metabolism of Alfuzosin can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Alfuzosin can be decreased when combined with Doxycycline.
Dronedarone
Alfuzosin may increase the QTc-prolonging activities of Dronedarone.
Droperidol
Alfuzosin may increase the QTc-prolonging activities of Droperidol.
Droxidopa
Alfuzosin may decrease the vasoconstricting activities of Droxidopa.
Edoxaban
The serum concentration of Alfuzosin can be increased when it is combined with Edoxaban.
Eliglustat
Alfuzosin may increase the QTc-prolonging activities of Eliglustat.
Enalapril
The serum concentration of Alfuzosin can be increased when it is combined with Enalapril.
Enalaprilat
The serum concentration of Alfuzosin can be increased when it is combined with Enalaprilat.
Enalaprilat Anhydrous
The serum concentration of Alfuzosin can be increased when it is combined with Enalaprilat.
Enzalutamide
The serum concentration of Alfuzosin can be decreased when it is combined with Enzalutamide.
Ephedrine
Alfuzosin may decrease the vasoconstricting activities of Ephedrine.
Epigallocatechin Gallate
The serum concentration of Alfuzosin can be increased when it is combined with Epigallocatechin Gallate.
Epinastine
Alfuzosin may decrease the vasoconstricting activities of Epinastine.
Epinephrine
Alfuzosin may decrease the vasoconstricting activities of Epinephrine.
Epoprostenol
Alfuzosin may increase the hypotensive activities of Epoprostenol.
Eprosartan
Alfuzosin may increase the hypotensive activities of Eprosartan.
Ergotamine
Alfuzosin may decrease the vasoconstricting activities of Ergotamine.
Erythromycin
The metabolism of Alfuzosin can be decreased when combined with Erythromycin.
Escitalopram
Alfuzosin may increase the QTc-prolonging activities of Escitalopram.
Esmolol
Esmolol may increase the orthostatic hypotensive activities of Alfuzosin.
Ethosuximide
The risk or severity of hypotension can be increased when Alfuzosin is combined with Ethosuximide.
Etilefrine
Alfuzosin may decrease the vasoconstricting activities of Etilefrine.
Felodipine
Alfuzosin may increase the hypotensive activities of Felodipine.
Fendiline
The risk or severity of hypotension can be increased when Alfuzosin is combined with Fendiline.
Fenoldopam
Alfuzosin may increase the hypotensive activities of Fenoldopam.
Fenoterol
Alfuzosin may decrease the vasoconstricting activities of Fenoterol.
Ferulic Acid
Alfuzosin may increase the hypotensive activities of Ferulic acid.
Fibrinolysis Inhibitor
The serum concentration of Alfuzosin can be increased when it is combined with Aprotinin.
Flecainide
Alfuzosin may increase the QTc-prolonging activities of Flecainide.
Fluconazole
The metabolism of Alfuzosin can be decreased when combined with Fluconazole.
Flunarizine
The risk or severity of hypotension can be increased when Alfuzosin is combined with Flunarizine.
Fluoxetine
Alfuzosin may increase the QTc-prolonging activities of Fluoxetine.
Flupenthixol
Alfuzosin may increase the QTc-prolonging activities of Flupentixol.
Fluspirilene
The risk or severity of hypotension can be increased when Alfuzosin is combined with Fluspirilene.
Fluvoxamine
The metabolism of Alfuzosin can be decreased when combined with Fluvoxamine.
Formoterol
Alfuzosin may decrease the vasoconstricting activities of Formoterol.
Fosamprenavir
The serum concentration of Alfuzosin can be increased when it is combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Alfuzosin can be increased when it is combined with Fosaprepitant.
Fosinopril
The serum concentration of Alfuzosin can be increased when it is combined with Fosinopril.
Fosphenytoin
The metabolism of Alfuzosin can be increased when combined with Fosphenytoin.
Fusidate
The serum concentration of Alfuzosin can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Alfuzosin can be increased when it is combined with Fusidic Acid.
Gabapentin
The risk or severity of hypotension can be increased when Alfuzosin is combined with Gabapentin.
Gadobenate
Alfuzosin may increase the QTc-prolonging activities of Gadobenic acid.
Gallopamil
The risk or severity of hypotension can be increased when Alfuzosin is combined with Gallopamil.
Gemifloxacin
Alfuzosin may increase the QTc-prolonging activities of Gemifloxacin.
Gemifloxacin Mesylate
Alfuzosin may increase the QTc-prolonging activities of Gemifloxacin.
Goserelin
Alfuzosin may increase the QTc-prolonging activities of Goserelin.
Granisetron
Alfuzosin may increase the QTc-prolonging activities of Granisetron.
Guanabenz
Alfuzosin may increase the hypotensive activities of Guanabenz.
Guanadrel
Alfuzosin may increase the hypotensive activities of Guanadrel.
Guanethidine
Alfuzosin may increase the hypotensive activities of Guanethidine.
Guanfacine
Alfuzosin may increase the hypotensive activities of Guanfacine.
Haloperidol
Alfuzosin may increase the QTc-prolonging activities of Haloperidol.
Hexoprenaline
Alfuzosin may decrease the vasoconstricting activities of Hexoprenaline.
Hydralazine
Alfuzosin may increase the hypotensive activities of Hydralazine.
Hydrochlorothiazide
Alfuzosin may increase the hypotensive activities of Hydrochlorothiazide.
Hydroflumethiazide
Alfuzosin may increase the hypotensive activities of Hydroflumethiazide.
Hypoxis hemerocallidea root extract
The serum concentration of Alfuzosin can be decreased when it is combined with St. John's Wort.
Ibutilide
Alfuzosin may increase the QTc-prolonging activities of Ibutilide.
Idelalisib
The serum concentration of Alfuzosin can be increased when it is combined with Idelalisib.
Iloperidone
Alfuzosin may increase the QTc-prolonging activities of Iloperidone.
Imatinib
The metabolism of Alfuzosin can be decreased when combined with Imatinib.
Imidapril
The serum concentration of Alfuzosin can be increased when it is combined with Imidapril.
Inamrinone
The risk or severity of hypotension can be increased when Alfuzosin is combined with Amrinone.
Indapamide
Alfuzosin may increase the hypotensive activities of Indapamide.
Indinavir
The serum concentration of Alfuzosin can be increased when it is combined with Indinavir.
INDINAVIR ANHYDROUS
The serum concentration of Alfuzosin can be increased when it is combined with Indinavir.
Indoramin
Alfuzosin may increase the hypotensive activities of Indoramin.
Irbesartan
Alfuzosin may increase the hypotensive activities of Irbesartan.
Isavuconazole
The serum concentration of Alfuzosin can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Alfuzosin can be decreased when combined with Isavuconazonium.
Isoetharine
Alfuzosin may decrease the vasoconstricting activities of Isoetarine.
Isoflurophate
The serum concentration of Alfuzosin can be increased when it is combined with Isoflurophate.
Isoproterenol
Alfuzosin may decrease the vasoconstricting activities of Isoprenaline.
Isoxsuprine
Alfuzosin may decrease the vasoconstricting activities of Isoxsuprine.
Isradipine
Alfuzosin may increase the hypotensive activities of Isradipine.
Itraconazole
The serum concentration of Alfuzosin can be increased when it is combined with Itraconazole.
Ivacaftor
The serum concentration of Alfuzosin can be increased when it is combined with Ivacaftor.
Ixazomib
The serum concentration of Alfuzosin can be increased when it is combined with Ixazomib.
Ketanserin
Alfuzosin may increase the hypotensive activities of Ketanserin.
Ketoconazole
The serum concentration of Alfuzosin can be increased when it is combined with Ketoconazole.
Labetalol
Alfuzosin may increase the hypotensive activities of Labetalol.
Lacidipine
Alfuzosin may increase the hypotensive activities of Lacidipine.
Lamotrigine
The risk or severity of hypotension can be increased when Alfuzosin is combined with Lamotrigine.
Latanoprost
Alfuzosin may increase the hypotensive activities of Latanoprost.
Lenvatinib
Alfuzosin may increase the QTc-prolonging activities of Lenvatinib.
Lenvatinib Mesylate
Alfuzosin may increase the QTc-prolonging activities of Lenvatinib.
Lepirudin
The serum concentration of Alfuzosin can be increased when it is combined with Lepirudin.
Lercanidipine
Alfuzosin may increase the hypotensive activities of Lercanidipine.
Leuprolide
Alfuzosin may increase the QTc-prolonging activities of Leuprolide.
Levetiracetam
The risk or severity of hypotension can be increased when Alfuzosin is combined with Levetiracetam.
Levofloxacin
Alfuzosin may increase the QTc-prolonging activities of Levofloxacin.
Levofloxacin Anhydrous
Alfuzosin may increase the QTc-prolonging activities of Levofloxacin.
Linagliptin
The serum concentration of Alfuzosin can be increased when it is combined with Linagliptin.
Lisinopril
The serum concentration of Alfuzosin can be increased when it is combined with Lisinopril.
Lisinopril Anhydrous
The serum concentration of Alfuzosin can be increased when it is combined with Lisinopril.
Lofexidine
Alfuzosin may increase the hypotensive activities of Lofexidine.
Loperamide
The risk or severity of hypotension can be increased when Alfuzosin is combined with Loperamide.
Lopinavir
The serum concentration of Alfuzosin can be increased when it is combined with Lopinavir.
Losartan
Alfuzosin may increase the hypotensive activities of Losartan.
Lovastatin
The metabolism of Alfuzosin can be decreased when combined with Lovastatin.
Luliconazole
The serum concentration of Alfuzosin can be increased when it is combined with Luliconazole.
Lumacaftor
The metabolism of Alfuzosin can be increased when combined with Lumacaftor.
Lumefantrine
Alfuzosin may increase the QTc-prolonging activities of Lumefantrine.
Macitentan
Alfuzosin may increase the hypotensive activities of Macitentan.
Magnesium Sulfate
The risk or severity of hypotension can be increased when Alfuzosin is combined with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The risk or severity of hypotension can be increased when Alfuzosin is combined with Magnesium sulfate.
Manidipine
Alfuzosin may increase the hypotensive activities of Manidipine.
Mecamylamine
Alfuzosin may increase the hypotensive activities of Mecamylamine.
Mephentermine
Alfuzosin may decrease the vasoconstricting activities of Mephentermine.
Mepirodipine
The risk or severity of hypotension can be increased when Alfuzosin is combined with Barnidipine.
Metaproterenol
Alfuzosin may decrease the vasoconstricting activities of Orciprenaline.
Metaraminol
Alfuzosin may decrease the vasoconstricting activities of Metaraminol.
Methadone
Alfuzosin may increase the QTc-prolonging activities of Methadone.
Methoxamine
Alfuzosin may decrease the vasoconstricting activities of Methoxamine.
Methsuximide
The risk or severity of hypotension can be increased when Alfuzosin is combined with Methsuximide.
Methyldopa
Alfuzosin may increase the hypotensive activities of Methyldopa.
METHYLDOPA ANHYDROUS
Alfuzosin may increase the hypotensive activities of Methyldopa.
Metipranolol
Alfuzosin may increase the hypotensive activities of Metipranolol.
Metolazone
Alfuzosin may increase the hypotensive activities of Metolazone.
Metoprolol
Alfuzosin may increase the hypotensive activities of Metoprolol.
Metyrosine
Alfuzosin may increase the hypotensive activities of Metyrosine.
Mibefradil
Alfuzosin may increase the hypotensive activities of Mibefradil.
Midodrine
Alfuzosin may decrease the vasoconstricting activities of Midodrine.
Mifepristone
The serum concentration of Alfuzosin can be increased when it is combined with Mifepristone.
Minoxidil
Alfuzosin may increase the hypotensive activities of Minoxidil.
Mirabegron
Alfuzosin may decrease the vasoconstricting activities of Mirabegron.
Mitotane
The serum concentration of Alfuzosin can be decreased when it is combined with Mitotane.
Moexipril
The serum concentration of Alfuzosin can be increased when it is combined with Moexipril.
Moxifloxacin
Alfuzosin may increase the QTc-prolonging activities of Moxifloxacin.
Moxonidine
Alfuzosin may increase the hypotensive activities of Moxonidine.
Nadolol
Alfuzosin may increase the hypotensive activities of Nadolol.
Naphazoline
Alfuzosin may decrease the vasoconstricting activities of Naphazoline.
Nebivolol
Alfuzosin may increase the hypotensive activities of Nebivolol.
Nefazodone
The serum concentration of Alfuzosin can be increased when it is combined with Nefazodone.
Nelfinavir
The serum concentration of Alfuzosin can be increased when it is combined with Nelfinavir.
Netupitant
The serum concentration of Alfuzosin can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Alfuzosin can be increased when combined with Nevirapine.
Nicardipine
Alfuzosin may increase the hypotensive activities of Nicardipine.
Nicorandil
Alfuzosin may increase the hypotensive activities of Nicorandil.
Nifedipine
The risk or severity of hypotension can be increased when Alfuzosin is combined with Nifedipine.
Nilotinib
Alfuzosin may increase the QTc-prolonging activities of Nilotinib.
Nilvadipine
Alfuzosin may increase the hypotensive activities of Nilvadipine.
Nimesulide
The risk or severity of hypotension can be increased when Alfuzosin is combined with Nimesulide.
Nimodipine
Alfuzosin may increase the hypotensive activities of Nimodipine.
Nisoldipine
Alfuzosin may increase the hypotensive activities of Nisoldipine.
Nitrendipine
Alfuzosin may increase the hypotensive activities of Nitrendipine.
Nitroglycerin
Alfuzosin may increase the hypotensive activities of Nitroglycerin.
Nitroprusside
Alfuzosin may increase the hypotensive activities of Nitroprusside.
Norepinephrine
Alfuzosin may decrease the vasoconstricting activities of Norepinephrine.
Nylidrin
Alfuzosin may decrease the vasoconstricting activities of Nylidrin.
O-PHENANTHROLINE
The serum concentration of Alfuzosin can be increased when it is combined with 1,10-Phenanthroline.
Octylonium
The risk or severity of hypotension can be increased when Alfuzosin is combined with Otilonium.
Ofloxacin
Alfuzosin may increase the QTc-prolonging activities of Ofloxacin.
Olaparib
The metabolism of Alfuzosin can be decreased when combined with Olaparib.
Olmesartan
Alfuzosin may increase the hypotensive activities of Olmesartan.
Olodaterol
Alfuzosin may decrease the vasoconstricting activities of Olodaterol.
Ondansetron
Alfuzosin may increase the QTc-prolonging activities of Ondansetron.
Osimertinib
The serum concentration of Alfuzosin can be increased when it is combined with Osimertinib.
Oxprenolol
Alfuzosin may increase the hypotensive activities of Oxprenolol.
Oxymetazoline
Alfuzosin may decrease the vasoconstricting activities of Oxymetazoline.
Palbociclib
The serum concentration of Alfuzosin can be increased when it is combined with Palbociclib.
Paliperidone
Alfuzosin may increase the QTc-prolonging activities of Paliperidone.
Panobinostat
Alfuzosin may increase the QTc-prolonging activities of Panobinostat.
Pargyline
Alfuzosin may increase the hypotensive activities of Pargyline.
Pazopanib
Alfuzosin may increase the QTc-prolonging activities of Pazopanib.
Penbutolol
Alfuzosin may increase the hypotensive activities of Penbutolol.
Pentamidine
Alfuzosin may increase the QTc-prolonging activities of Pentamidine.
Pentobarbital
The metabolism of Alfuzosin can be increased when combined with Pentobarbital.
Perflutren
Alfuzosin may increase the QTc-prolonging activities of Perflutren.
Perindopril
The serum concentration of Alfuzosin can be increased when it is combined with Perindopril.
Phenobarbital
The metabolism of Alfuzosin can be increased when combined with Phenobarbital.
Phenoxybenzamine
Alfuzosin may increase the hypotensive activities of Phenoxybenzamine.
Phentolamine
Alfuzosin may increase the hypotensive activities of Phentolamine.
Phentolamine Mesylate
Alfuzosin may increase the hypotensive activities of Phentolamine.
Phenylephrine
Alfuzosin may decrease the vasoconstricting activities of Phenylephrine.
Phenylpropanolamine
Alfuzosin may decrease the vasoconstricting activities of Phenylpropanolamine.
Phenytoin
The metabolism of Alfuzosin can be increased when combined with Phenytoin.
Pimozide
Alfuzosin may increase the QTc-prolonging activities of Pimozide.
Pinacidil
Alfuzosin may increase the hypotensive activities of Pinacidil.
Pinaverium
The risk or severity of hypotension can be increased when Alfuzosin is combined with Pinaverium.
Pindolol
Alfuzosin may increase the hypotensive activities of Pindolol.
Pirbuterol
Alfuzosin may decrease the vasoconstricting activities of Pirbuterol.
Polythiazide
Alfuzosin may increase the hypotensive activities of Polythiazide.
Posaconazole
The serum concentration of Alfuzosin can be increased when it is combined with Posaconazole.
Practolol
Practolol may increase the orthostatic hypotensive activities of Alfuzosin.
Prazosin
Alfuzosin may increase the hypotensive activities of Prazosin.
Prenylamine
The risk or severity of hypotension can be increased when Alfuzosin is combined with Prenylamine.
Primaquine
Alfuzosin may increase the QTc-prolonging activities of Primaquine.
Primidone
The metabolism of Alfuzosin can be increased when combined with Primidone.
Procainamide
Alfuzosin may increase the QTc-prolonging activities of Procainamide.
Procaterol
Alfuzosin may decrease the vasoconstricting activities of Procaterol.
Promazine
Alfuzosin may increase the QTc-prolonging activities of Promazine.
Propafenone
Alfuzosin may increase the QTc-prolonging activities of Propafenone.
Propranolol
Alfuzosin may increase the hypotensive activities of Propranolol.
Pseudoephedrine
Alfuzosin may decrease the vasoconstricting activities of Pseudoephedrine.
Quetiapine
Alfuzosin may increase the QTc-prolonging activities of Quetiapine.
Quetiapine fumarate
Alfuzosin may increase the QTc-prolonging activities of Quetiapine.
Quinapril
The serum concentration of Alfuzosin can be increased when it is combined with Quinapril.
Quinidine
Alfuzosin may increase the QTc-prolonging activities of Quinidine.
Quinine
Alfuzosin may increase the QTc-prolonging activities of Quinine.
Racecadotril
The serum concentration of Alfuzosin can be increased when it is combined with Racecadotril.
Racepinephrine
Alfuzosin may decrease the vasoconstricting activities of Racepinephrine.
Ramipril
Alfuzosin may increase the hypotensive activities of Ramipril.
Ranolazine
The metabolism of Alfuzosin can be decreased when combined with Ranolazine.
Reproterol
Alfuzosin may decrease the vasoconstricting activities of Reproterol.
Rescinnamine
Alfuzosin may increase the hypotensive activities of Rescinnamine.
Reserpine
Alfuzosin may increase the hypotensive activities of Reserpine.
Rifabutin
The metabolism of Alfuzosin can be increased when combined with Rifabutin.
Rifampin
The metabolism of Alfuzosin can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Alfuzosin can be increased when combined with Rifapentine.
Rilmenidine
Alfuzosin may increase the hypotensive activities of Rilmenidine.
Riociguat
Alfuzosin may increase the hypotensive activities of Riociguat.
Ritodrine
Alfuzosin may decrease the vasoconstricting activities of Ritodrine.
Ritonavir
The serum concentration of Alfuzosin can be increased when it is combined with Ritonavir.
Rivaroxaban
The serum concentration of Alfuzosin can be increased when it is combined with Rivaroxaban.
Rucaparib
The metabolism of Alfuzosin can be decreased when combined with Rucaparib.
Salmeterol
Alfuzosin may decrease the vasoconstricting activities of Salmeterol.
Saquinavir
The serum concentration of Alfuzosin can be increased when it is combined with Saquinavir.
Saquinavir Mesylate
The serum concentration of Alfuzosin can be increased when it is combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Alfuzosin can be decreased when used in combination with Sarilumab.
Saxagliptin
The serum concentration of Alfuzosin can be increased when it is combined with Saxagliptin.
Saxagliptin Anhydrous
The serum concentration of Alfuzosin can be increased when it is combined with Saxagliptin.
Selexipag
Alfuzosin may increase the hypotensive activities of Selexipag.
Sildenafil
Sildenafil may increase the hypotensive activities of Alfuzosin.
Silodosin
Alfuzosin may increase the antihypertensive activities of Silodosin.
Siltuximab
The serum concentration of Alfuzosin can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Alfuzosin can be increased when it is combined with Simeprevir.
Sitagliptin
The serum concentration of Alfuzosin can be increased when it is combined with Sitagliptin.
Sitagliptin Phosphate
The serum concentration of Alfuzosin can be increased when it is combined with Sitagliptin.
Sotalol
Sotalol may increase the orthostatic hypotensive activities of Alfuzosin.
Spirapril
The serum concentration of Alfuzosin can be increased when it is combined with Spirapril.
ST. JOHN'S WORT EXTRACT
The serum concentration of Alfuzosin can be decreased when it is combined with St. John's Wort.
Sulfisoxazole
The metabolism of Alfuzosin can be decreased when combined with Sulfisoxazole.
Synephrine
Alfuzosin may decrease the vasoconstricting activities of Synephrine.
Tadalafil
Tadalafil may increase the hypotensive activities of Alfuzosin.
Talinolol
Alfuzosin may increase the hypotensive activities of Talinolol.
Tamsulosin
Alfuzosin may increase the antihypertensive activities of Tamsulosin.
Telaprevir
The serum concentration of Alfuzosin can be increased when it is combined with Telaprevir.
Telavancin
Alfuzosin may increase the QTc-prolonging activities of Telavancin.
Telithromycin
The serum concentration of Alfuzosin can be increased when it is combined with Telithromycin.
Telmisartan
Alfuzosin may increase the hypotensive activities of Telmisartan.
Terazosin
Alfuzosin may increase the antihypertensive activities of Terazosin.
Terbutaline
Alfuzosin may decrease the vasoconstricting activities of Terbutaline.
Terbutaline Sulfate
Alfuzosin may decrease the vasoconstricting activities of Terbutaline.
Terlipressin
Alfuzosin may increase the hypotensive activities of Terlipressin.
Tetrabenazine
Alfuzosin may increase the QTc-prolonging activities of Tetrabenazine.
Theodrenaline
Alfuzosin may increase the hypotensive activities of Theodrenaline.
Thioridazine
Alfuzosin may increase the QTc-prolonging activities of Thioridazine.
Tibolone
Alfuzosin may increase the hypotensive activities of Tibolone.
Ticlopidine
The metabolism of Alfuzosin can be decreased when combined with Ticlopidine.
Timolol
Alfuzosin may increase the hypotensive activities of Timolol.
Timolol Anhydrous
Alfuzosin may increase the hypotensive activities of Timolol.
Tipranavir
The serum concentration of Alfuzosin can be increased when it is combined with Tipranavir.
Tizanidine
Alfuzosin may decrease the vasoconstricting activities of Tizanidine.
Tocilizumab
The serum concentration of Alfuzosin can be decreased when it is combined with Tocilizumab.
Tolazoline
Alfuzosin may increase the hypotensive activities of Tolazoline.
Tolfenamic Acid
The risk or severity of hypotension can be increased when Alfuzosin is combined with Tolfenamic Acid.
Toremifene
Alfuzosin may increase the QTc-prolonging activities of Toremifene.
Torsemide
Alfuzosin may increase the hypotensive activities of Torasemide.
Trandolapril
The serum concentration of Alfuzosin can be increased when it is combined with Trandolapril.
Tranilast
The risk or severity of hypotension can be increased when Alfuzosin is combined with Tranilast.
Travoprost
Alfuzosin may increase the hypotensive activities of Travoprost.
Treprostinil
Alfuzosin may increase the hypotensive activities of Treprostinil.
Trichlormethiazide
Alfuzosin may increase the hypotensive activities of Trichlormethiazide.
Trimebutine
The risk or severity of hypotension can be increased when Alfuzosin is combined with Trimebutine.
Trimethadione
The risk or severity of hypotension can be increased when Alfuzosin is combined with Trimethadione.
Trimethaphan
Alfuzosin may increase the hypotensive activities of Trimethaphan.
Tulobuterol
Alfuzosin may decrease the vasoconstricting activities of Tulobuterol.
UNOPROSTONE
Alfuzosin may increase the hypotensive activities of Unoprostone.
Urapidil
Alfuzosin may increase the hypotensive activities of Urapidil.
Valsartan
Alfuzosin may increase the hypotensive activities of Valsartan.
Vandetanib
Alfuzosin may increase the QTc-prolonging activities of Vandetanib.
Vardenafil
Vardenafil may increase the hypotensive activities of Alfuzosin.
Vemurafenib
The serum concentration of Alfuzosin can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Alfuzosin can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Alfuzosin can be decreased when combined with Verapamil.
Vildagliptin
The serum concentration of Alfuzosin can be increased when it is combined with Vildagliptin.
Vincamine
Alfuzosin may increase the hypotensive activities of Vincamine.
Vinpocetine
Alfuzosin may increase the hypotensive activities of Vinpocetine.
Voriconazole
The serum concentration of Alfuzosin can be increased when it is combined with Voriconazole.
Xamoterol
Alfuzosin may decrease the vasoconstricting activities of Xamoterol.
Xylometazoline
Alfuzosin may increase the hypotensive activities of Xylometazoline.
Ziconotide
The risk or severity of hypotension can be increased when Alfuzosin is combined with Ziconotide.
Ziprasidone
Alfuzosin may increase the QTc-prolonging activities of Ziprasidone.
Zofenopril
The serum concentration of Alfuzosin can be increased when it is combined with Zofenopril.
Zonisamide
The risk or severity of hypotension can be increased when Alfuzosin is combined with Zonisamide.
Zuclopenthixol
Alfuzosin may increase the QTc-prolonging activities of Zuclopenthixol.
